Evaluation of Health Technology Assessment Frameworks for In Vivo Diagnostics: Assessing Methodological Gaps and Implications for Market Access
Bibliographic record
Abstract
OBJECTIVES: This study investigates the evaluation of in vivo diagnostics, particularly molecular imaging (MI) tracers and contrast media (CM), within health technology assessment (HTA) frameworks across 28 countries. The aim is to identify variations in HTA methodologies and highlight gaps in the evaluation of diagnostics, focusing on market access and reimbursement. METHODS: Guidance documents from Ministry of Health, national insurers, and HTA organizations were reviewed to assess roles and methodologies for evaluating in vitro diagnostics (IVDs), pharmaceuticals, and in vivo diagnostics. HTA organizations were grouped into 5 categories based on assessment processes and legal influence. A mapping methodology created regulatory-to-reimbursement process maps, resulting in 2 taxonomies. Representative countries from each group were analyzed for evidence requirements for MI tracers and CM. Five published HTA case studies were used to validate findings and evaluate the impact of HTA decisions on coverage and reimbursement. RESULTS: The study found that IVDs were universally evaluated as medical technologies, whereas MI tracers and CM were often evaluated as pharmaceuticals, with diagnostic modalities considered separately. HTA frameworks in 11 countries were analyzed, revealing variation in how evidence requirements were defined. Case studies revealed discrepancies in reimbursement decisions despite similar clinical evidence, highlighting inconsistencies in HTA methodologies. CONCLUSIONS: This study identifies gaps in HTA frameworks for evaluating in vivo diagnostics, including reliance on pharmaceutical-centric models, lack of standardization, and inconsistent methodologies across markets. These gaps pose barriers to access and reimbursement for MI tracers and CM, emphasizing the need for methodologies tailored specifically to in vivo diagnostics.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.566 | 0.744 |
| Meta-epidemiology (narrow) | 0.003 | 0.002 |
| Meta-epidemiology (broad) | 0.007 | 0.005 |
| Bibliometrics | 0.009 | 0.009 |
| Science and technology studies | 0.001 | 0.009 |
| Scholarly communication | 0.020 | 0.018 |
| Open science | 0.010 | 0.012 |
| Research integrity | 0.008 | 0.008 |
| Insufficient payload (model declined to judge) | 0.007 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".